Clik here to view.
Viveve ups share count, lowers share price in $13.5m NASDAQ uplisting
Viveve (OTC:VIVMD) today tweaked the value of its uplisting from the over-the-counter exchange to the NASDAQ board, expecting to sell 2.7 million shares at $5 per share to bring in $13.5 million....
View ArticleClik here to view.
Lombard touts 5-year Aorfix stent graft data
Lombard Medical Technologies (NSDQ:EVAR) yesterday released 5-year results from the Pythagoras trial of its Aorfix, which aimed to evaluate the safety and effectiveness of the stent graft in treating...
View ArticleClik here to view.
Abbott touts clinical trial of its wearable glucose monitor at ADA
Abbott (NYSE:ABT) touted clinical trial results of its wearable Freestyle Libre glucose monitor at the annual meeting of the American Diabetes Association in New Orleans. Compared to users of...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for June 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Medtech legend Villafaña is at it again with Medical 21
One of the most prolific and successful entrepreneurs in the medical device space, Dr. Manny Villafaña, is at it again with a new startup. Villafaña, the founder of Guidant and St. Jude Medical...
View ArticleClik here to view.
Neuspera closes $9m funding round
NeuSpera Medical closed an $9 million round of equity financing, according to a new SEC filing from the company. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation...
View ArticleClik here to view.
They’re here: New draft European medical device & IVD regulations published
By Stewart Eisenhart, Emergo Group European lawmakers and regulators have published eagerly awaited draft versions of new medical device and IVD regulations earlier than anticipated. Emergo consultants...
View ArticleClik here to view.
Aspire Bariatrics wins FDA nod for weight-loss stomach tube
Aspire Bariatrics said yesterday it won FDA premarket approval for its AspireAssist device designed to treat obesity by draining a portion of the stomach’s contents after meals. The system is placed...
View ArticleClik here to view.
Medtronic inks partnership deal with self-management program dev Canary Health
Medtronic (NYSE:MDT) is partnering with digital health self-management program developer Canary Health to resell and distribute its full suite of chronic disease self-management programs, including its...
View ArticleClik here to view.
Zimmer Biomet breached deferred prosecution deal, U.S. says
(Reuters) – Medical device maker Zimmer Biomet (NYSE:ZBH) breached a deferred prosecution agreement it reached in 2012 to resolve a foreign corruption investigation, U.S. prosecutors said in a court...
View ArticleClik here to view.
Suit claims Intuitive’s da Vinci caused metallic microemboli in patient’s brains
A group of heart surgery patients are taking Intuitive Surgical (NSDQ:ISRG) to court, claiming its da Vinci surgical robot caused metallic debris to end up in their brains after mitral valve surgery....
View ArticleClik here to view.
Silk Road touts TCAR study data
Silk Road Medical disclosed encouraging new clinical data for its Enroute device, which is cleared to help protect the brain from stroke while implanting a transcarotid artery stent. The company said...
View ArticleClik here to view.
Nevro closes over-subscribed $173m round
Nevro Corp. (NYSE:NVRO) said Monday it closed a $172.5 million round of financing, including a fully-exercised underwriter’s over-allotment option, through the sale of 1.75% convertible senior notes...
View ArticleClik here to view.
Philips Respironics launches patient adherence system
The Respironics division at Philips (NYSE:PHG) yesterday released the Patient Adherence Management Services designed to support new patients transitioning into continuous positive airway pressure sleep...
View ArticleClik here to view.
Frenova discloses F1RST Up clinical trial accelerator participants
Four months after it launched a clinical trial accelerator, Fresenius‘s (NYSE:FMS) renal research arm Frenova disclosed the initial participants. Fourteen research centers around the U.S. will take...
View ArticleClik here to view.
Biotronik wins CE Mark for Magmaris bioresorbable scaffold
Biotronik said today it won CE Mark for its Magmaris magnesium bioresorbable scaffold designed to treat coronary artery disease. Data from the Biosolve-II trial of the stent was previously published in...
View ArticleClik here to view.
4tech launches transcatheter tricuspid valve repair feasibility trial
Transcatheter tricuspid heart valve repair device developer 4Tech said today it launched a feasibility trial of its TriCinch device designed to treat patients suffering from tricuspid regurgitation....
View ArticleClik here to view.
Bluewind Medical wins CE Mark for OAB neuromod device
Neurostim developer Bluewind Medical said today it won CE Mark approval in the European union for its OAB-1000 system designed to treat overactive bladder through wireless neurostimulation. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for June 15, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Allergan touts FDA acceptance of 510(k) application for Xen IOP reducing gel...
Allergan (NYSE: AGN) said today the FDA accepted the 510(k) premarket notification application for its Xen glaucoma treatment gel stent system, which consists of the Xen45 gel stent and Xen injector....
View Article